Sensus Healthcare, Inc. (SRTS): Price and Financial Metrics
GET POWR RATINGS... FREE!
SRTS Stock Summary
- SRTS has a higher market value than only 7.07% of US stocks; more precisely, its current market capitalization is $59,332,040.
- The ratio of debt to operating expenses for Sensus Healthcare Inc is higher than it is for about merely 12.6% of US stocks.
- With a year-over-year growth in debt of -50.87%, Sensus Healthcare Inc's debt growth rate surpasses only 9.01% of about US stocks.
- If you're looking for stocks that are quantitatively similar to Sensus Healthcare Inc, a group of peers worth examining would be OSPN, WKEY, ULBI, FEIM, and ISSC.
- SRTS's SEC filings can be seen here. And to visit Sensus Healthcare Inc's official web site, go to www.sensushealthcare.com.
SRTS Valuation Summary
- In comparison to the median Healthcare stock, SRTS's price/earnings ratio is 178.36% lower, now standing at -28.6.
- SRTS's price/sales ratio has moved down 2.5 over the prior 62 months.
- Over the past 62 months, SRTS's price/earnings ratio has gone up 510.7.
Below are key valuation metrics over time for SRTS.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| SRTS | 2021-08-31 | 3.9 | 2.9 | -28.6 | -21.8 |
| SRTS | 2021-08-30 | 4.0 | 3.0 | -29.3 | -22.4 |
| SRTS | 2021-08-27 | 4.0 | 3.0 | -29.4 | -22.5 |
| SRTS | 2021-08-26 | 3.9 | 2.9 | -28.5 | -21.7 |
| SRTS | 2021-08-25 | 3.9 | 3.0 | -29.0 | -22.2 |
| SRTS | 2021-08-24 | 3.8 | 2.9 | -28.0 | -21.2 |
SRTS Stock Price Chart Interactive Chart >
SRTS Price/Volume Stats
| Current price | $3.51 | 52-week high | $6.09 |
| Prev. close | $3.57 | 52-week low | $2.32 |
| Day low | $3.51 | Volume | 15,000 |
| Day high | $3.67 | Avg. volume | 199,319 |
| 50-day MA | $3.64 | Dividend yield | N/A |
| 200-day MA | $3.84 | Market Cap | 58.34M |
Sensus Healthcare, Inc. (SRTS) Company Bio
Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides Sentinel service program, which offers its customers protection for their SRT-100 and SRT-100 Vision systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is based in Boca Raton, Florida.
Latest SRTS News From Around the Web
Below are the latest news stories about Sensus Healthcare Inc that investors may wish to consider to help them evaluate SRTS as an investment opportunity.
Sensus Healthcare to Participate at H.C. Wainwright 23rd Annual Global Investment ConferenceBoca Raton, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announced that Joe Sardano, chairman and chief executive officer, will present at the H.C. Wainwright 23 rd Annual Global Investment Conference to be held virtually from September 13 15, 2021. |
Global Intraoperative Radiation Therapy Market To Reflect Impressive Growth Rate by 2028||Players-IntraOp Medical, Inc., Ariane Medical Systems Ltd, Varian Medical Systems, Inc., Carl Zeiss AG, Eckert & Ziegler, Sensus Healthcare, iCAD IncThis Intraoperative Radiation Therapy report provides complete analysis of the market on global and regional level. It inspects the development rate and the market value dependent on the market elements and growth initiating factors. The market |
BioFlorida Announces Five New Board MembersWEST PALM BEACH, Fla. , Aug. 11, 2021 /PRNewswire/ -- BioFlorida has announced five new board members who will support the organization''s effort to grow the life sciences industry in Florida . "The life sciences industry in Florida is vibrant, and we''re excited to welcome Thomas Equels of AIM ImmunoTech, Mark Friedman , PhD of Axogen, Geoff Green of Longeveron, Adam Grossman of ADMA Biologics, and Joe Sardano of Sensus Healthcare," said Nancy Bryan , President and CEO of BioFlorida. "Our new board members are leaders in their fields with a passion to unite with our diverse Board of Directors representing the various sectors and regions in Florida with a collective goal to advance the impressive, diverse life sciences ecosystem." Today, the life sciences industry in the state represent... |
Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q2 2021 Results - Earnings Call TranscriptNo summary available. |
Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Tops Revenue EstimatesSensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 60.00% and 33.12%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock? |
SRTS Price Returns
| 1-mo | 5.41% |
| 3-mo | -17.02% |
| 6-mo | -10.46% |
| 1-year | 36.05% |
| 3-year | -53.75% |
| 5-year | -43.39% |
| YTD | -9.07% |
| 2020 | 9.04% |
| 2019 | -52.23% |
| 2018 | 43.60% |
| 2017 | -1.71% |
| 2016 | N/A |
Continue Researching SRTS
Want to see what other sources are saying about Sensus Healthcare Inc's financials and stock price? Try the links below:Sensus Healthcare Inc (SRTS) Stock Price | Nasdaq
Sensus Healthcare Inc (SRTS) Stock Quote, History and News - Yahoo Finance
Sensus Healthcare Inc (SRTS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...